Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QiShen YiQi Dropping Pills for HFpEF Myocardial Fibrosis and Strain (Notch Pathway, Speckle Tracking)
ChiCTR2600117679Phase 4Recruiting
- Sponsor
- Zhejiang Hospital
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Qishenyiqi Dripping Pills in heart failure with preserved ejection fraction (HFpEF) (2 arms), sponsored by Zhejiang Hospital. Primary endpoints: TCM syndrome score, 6-minute walk test distance and 1 more. Started Jan 2026; status: recruiting.
02
Drugs
Qishenyiqi Dripping Pills
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on ChiCTR2600117679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117679.